Afya (AFYA) Q2 2023: Digital Services Up 28% as B2B Expansion Accelerates Revenue Mix Shift
Afya’s Q2 showcased robust top-line growth, but margin dilution from digital and new campus integration signals a structural business mix shift. Management’s reaffirmed guidance and ambitious 2028 targets underscore confidence in multi-segment scaling, even as regulatory and funding headwinds loom. Investors should watch for execution on digital B2B and continued education ramp as key levers for future profitability and market share gains.
Summary
- Digital Revenue Mix Rising: B2B and digital services growth is reshaping margin structure and future segment weighting.
- Acquisitions and Seat Expansion: Integration of new campuses and organic seat additions are driving scale but compressing near-term margins.
- Margin Watchpoint: Segment mix shift and regulatory funding changes will test operational leverage in coming quarters.
Business Overview
Afya is the leading medical education and digital health platform in Brazil, generating revenue from three core segments: undergraduate medical education (tuition from medical students), continuing education (postgraduate and specialty courses), and digital health services (B2B and B2P, business-to-physician, digital offerings). The company monetizes its scale in medical seats, course portfolio, and digital ecosystem, serving nearly a third of Brazil’s medical students and physicians with both physical and digital solutions.
Performance Analysis
Q2 delivered strong top-line growth, with adjusted net revenue up 24% year-over-year, fueled by higher tuition, seat expansion, and a surge in continuing education and digital services. Cash flow from operations reached a record, with 99% cash conversion highlighting the business’s capital efficiency. However, adjusted EBITDA margin compressed slightly due to the growing share of lower-margin digital and new acquisition revenues, and the ramp-up of recently acquired campuses.
Segment dynamics reveal a multi-speed business: undergraduate medical education remains the largest contributor, but continuing education net revenue grew 50% year-over-year, and digital services climbed 28%, reflecting growing B2B traction. Digital now represents a meaningful driver, with over 282,000 monthly active users and more than 100 B2B pharma contracts. Net debt increased with acquisitions, but free cash generation offset a portion of the leverage, keeping the balance sheet robust.
- Digital Acceleration: Digital health services revenue rose 28%, driven by B2B and B2P expansion, but margins lag traditional segments.
- Continued Education Surge: Net revenue in continuing education jumped 50%, reflecting strong intake and new course launches.
- Margin Compression: EBITDA margin fell 15 basis points as digital and new campus revenues dilute blended profitability.
Integration of acquisitions and the evolving segment mix will continue to shape both growth and profitability, requiring careful monitoring of operational leverage and cost discipline.
Executive Commentary
"Once again, we are proud to present the strong execution of our unique business model, combining high growth in all three segments, profitability and strong cash generation, proving its resilience."
Vigílio Gibon, CEO
"The adjusted EBITDA margin reduction is due to the mix of net revenues with higher participations of the digital and continuing education segments, and the consolidations of four new Mais Médicos campuses...which are performing better than expected, but still present lower margins when compared to the integrated companies."
Luís André Blanco, CFO
Strategic Positioning
1. Digital Health Platform Expansion
Afya’s digital segment is rapidly scaling, targeting both B2B (pharma and healthcare companies) and B2P (physicians) markets. The launch of RxInsights, a data intelligence platform for pharma, exemplifies the move toward higher-value, recurring digital offerings. This segment is set to become a core growth lever, with management targeting R$1.2 billion in digital revenue by 2028.
2. Seat Growth and Capacity Scaling
Seat expansion remains a central growth vector, with 3,113 operating seats (up 25% YoY) and a target to reach 32,000 students by 2028. Growth comes both organically and through acquisitions, with a disciplined approach to integrating new campuses into Afya’s shared services and academic model.
3. Continuing Education and Course Diversification
Continuing education is recovering post-pandemic, with robust intake and new course launches propelling 50% YoY revenue growth. Management sees a pathway to quadruple segment revenue by 2028, leveraging demand for postgraduate and specialty medical training.
4. Integrated Brand and Ecosystem Strategy
Afya is consolidating its brand architecture, aiming to become the top-of-mind hub for medical students and physicians. By unifying digital and educational offerings under one brand, the company seeks to drive engagement, cross-sell, and up-sell throughout the medical journey.
5. Regulatory and Funding Navigation
Recent regulatory changes to FIES funding and seat allocation present both risk and opportunity. Management is actively engaged in sector advocacy to limit negative impacts from funding retention rates and to ensure fair allocation of medical seats, which will be critical for future growth and margin protection.
Key Considerations
This quarter marks a strategic inflection as Afya transitions from a pure-play educator to a diversified digital health platform. Investors must weigh the benefits of top-line growth and ecosystem expansion against margin headwinds and regulatory uncertainty.
Key Considerations:
- Digital Margin Dilution: Rapid digital revenue growth is structurally lowering blended EBITDA margins, requiring scale for profitability catch-up.
- Acquisition Integration Pace: New campus integrations are on track but temporarily depress group margins; operational leverage depends on successful migration to shared services.
- Regulatory Funding Volatility: FIES contribution rate increases and seat allocation rules are sector-wide headwinds, with ongoing advocacy and potential legislative relief.
- Cash Generation Resilience: High cash conversion (99%) and robust operating cash flow support continued investment and deleveraging, despite acquisition-driven net debt uptick.
Risks
Regulatory risk remains elevated, with FIES funding retention rates and seat allocation under government review. Digital margin dilution could persist if B2B and B2P offerings scale slower than expected or require sustained investment. Acquisition integration risk is present, as new campuses initially operate at lower profitability. Sector-wide funding changes and macroeconomic volatility may also impact student demand and payment behavior.
Forward Outlook
For Q3 and Q4 2023, Afya guided to:
- Adjusted net revenue of R$2.75 to R$2.85 billion for FY 2023
- Adjusted EBITDA of R$1.1 to R$1.2 billion for FY 2023
Management reaffirmed guidance, citing full medical school occupancy and robust operating momentum. Key factors shaping guidance:
- FG FIES contribution rate impact already incorporated in outlook
- Continued ramp of digital B2B engagements and new course launches
Takeaways
Afya’s Q2 results underscore a business in transition, with digital and continuing education scaling rapidly but shifting the margin narrative. Execution on integration and digital monetization will determine the next phase of value creation.
- Digital and Continuing Education Drive Growth: Both segments saw outsized YoY gains, but require scale and integration for margin normalization.
- Margin Watch as Mix Shifts: Near-term profitability diluted by segment mix and new campus ramp, but operational leverage remains a medium-term lever.
- Execution and Regulatory Navigation Key: Investors should monitor digital B2B ramp, campus integration, and evolving FIES policy for signals on sustainable growth and risk mitigation.
Conclusion
Afya delivered strong growth across all segments, but the evolving revenue mix and regulatory environment introduce new complexities. Strategic focus on digital platform scaling and disciplined integration will be critical to sustaining growth and restoring margin expansion.
Industry Read-Through
Afya’s results highlight a sector-wide pivot toward digital health and B2B engagement, as traditional education providers seek new growth vectors. Margin compression from digital expansion is likely to be a recurring theme for peers with similar diversification strategies. Regulatory funding volatility around FIES is a material risk for all Brazilian higher education operators, with sector advocacy and legislative developments worth close watch. For investors in education and healthtech, Afya’s segment mix evolution and digital platform scaling provide a blueprint—and a caution—on the tradeoff between growth and profitability in a regulated, fast-evolving market.